New York, USA, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Hypertension Clinical Trials Pipeline Analysis: 90+ Companies are Working to Improve the Treatment Space | DelveInsight

As per a statement of World Health Organization (WHO), Hypertension is one of the silent killers in 21st century and is one of the biggest global public health concerns. Factors like technological advancement, a growing aging population, and people affected by diabetes, and high blood pressure are favoring the market. Some of the key players contributing to the worldwide anti-hypertensive medication market include Quantum Genomics, Nicox, Santen Pharmaceuticals, Ionis Pharmaceuticals, United Therapeutics Corporation, and several others.

DelveInsights 'Hypertension Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline hypertension therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the hypertension pipeline domain.

Key Takeaways from the Hypertension Pipeline Report

Request a sample and discover the recent advances in hypertension treatment drugs @Hypertension Pipeline Report

The hypertension pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage hypertension products, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the hypertension pipeline landscape.

Hypertension Overview

High blood pressure (hypertension) is a common condition in which the blood's long-term force against your artery walls is high enough to cause health problems such as heart disease. Age, smoking, drinking, overweight are among the prominent factors for causes of hypertension.

Even when blood pressure readings reach dangerously high levels, most people with high blood pressure have no hypertension symptoms. Some people with high blood pressure may experience headaches, shortness of breath, or nosebleeds. Still, these signs and hypertension symptoms aren't specific and usually don't appear until the high blood pressure has progressed to a severe or life-threatening level.

Several tests such as ECG, EKG, Echocardiogram, Ambulatory monitoring, la tests, and others are used for hypertension diagnosis.

Find out more about hypertension medications @Hypertension Treatment Drugs

A snapshot of the Hypertension Pipeline Drugs mentioned in the report:

Learn more about the emerging hypertension pipeline therapies @Hypertension Clinical Trials

Hypertension Therapeutics Assessment

Thehypertension pipelinereport proffers an integral view of the hypertension emerging novel therapies segmented by stage, product type,molecule type, mechanism of action, and route of administration.

Scope of the Hypertension Pipeline Report

Dive deep into rich insights for drugs for hypertension treatment, visit @Hypertension Treatment

Table of Contents

For further information on the hypertension pipeline therapeutics, reach out @Hypertension Drugs

Related Reports

Hypertension Epidemiology Forecast

Hypertension Epidemiology Forecast 2032 report delivers an in-depth understanding of the disease, historical and forecasted hypertension epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Pulmonary Hypertension Market

Pulmonary Hypertension Market Insights, Epidemiology, and Market Forecast 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key pulmonary hypertension companies, including Cumberland Pharmaceuticals, AstraZeneca, Aerovate Therapeutics, Celon Pharma, Camurus, ATXA Therapeutics, among others.

Pulmonary Hypertension Pipeline

Pulmonary Hypertension Pipeline Insight 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key pulmonary arterial hypertension companies, including Reata Pharmaceuticals, Pharmosa BioPharm, United Therapeutics Corporation, Acceleron Pharma, Bellerophon Therapeutics, among others.

Pulmonary Arterial Hypertension Pipeline

Pulmonary Arterial Hypertension Pipeline Insight 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key pulmonary arterial hypertension companies, including Merck, Complexa, Acceleron Pharma, Ribomic, among others.

Pulmonary Arterial Hypertension Market

Pulmonary Arterial Hypertension Market Insights, Epidemiology, and Market Forecast 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key pulmonary arterial hypertension companies including Merck, Complexa, Acceleron Pharma, Ribomic, among others.

Pulmonary Arterial Hypertension Epidemiology Forecast

Pulmonary Arterial Hypertension Epidemiology Forecast 2032 report delivers an in-depth understanding of the disease, historical and forecasted pulmonary arterial hypertension epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Cardiac Output Monitors Market

Cardiac Output Monitors Market Insight, Competitive Landscape, and Market Forecast 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cardiac output monitors companies, including Osypka Medical GmbH, CNSystems Medizintechnik GmbH., Uscom, Deltex Medical Limited, among others.

Other Trending Reports

Goitre Market | Thymus Cancer Market | US Healthcare Outlook Report | Venous Stenosis Market | Negative Pressure Wound Therapy Systems Market | Metrorrhagia Market | Dysfunctional Uterine Bleeding Market | Hypereosinophilic Syndrome Market | Age-related Vision Dysfunction Market | Dental Lasers Market | CRISPR Therapies Pipeline Insight | Cell And Gene Therapy For Multiple Myeloma Market | Drug Hypersensitivity Market | Dysthymia Market | Persistent Depressive Disorder Market | Cancer Vaccines Market | Weight Loss/Weight Management (Obesity) Market | Food Allergy Market | Obsessive-Compulsive Disorder Market | Tumor Ablation Market | Physiotherapy Equipment Market | CAR-T Pipeline Insight | Anti-hypertension Market | Radiofrequency Ablation Devices Market | Global Messenger RNA (mRNA)-based Vaccines and Therapeutics Market | Gastro Intestinal Bleeding Market | Trastuzumab Biosimilars Insight | Varicose Veins Market | Germ Cell Tumor Market | Intracardiac Echocardiography Devices Market | India Healthcare Outlook Report | Crows Feet Market Insight | Seborrhoeic Dermatitis Market | Injectable Drug Delivery Devices Market | Structural Heart Devices Market | Substance (Drug) Abuse Market

Related Healthcare Blogs

Pulmonary Arterial Hypertension Treatment Space

Upcoming Cardiovascular Diseases Drugs

Key Companies in the Cardiology Segment

Heart Failure Market

AboutDelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences.

Connect with us at LinkedIn

Link:
Hypertension Clinical Trials Pipeline Analysis: 90+ Companies are Working to Improve the Treatment Space | DelveInsight - GlobeNewswire